Extended selection criteria, beyond the original Milan criteria for choosing LT as the treatment of choice, have been in practice at many centers the world over, the latest being the total tumor volume (≤115 cm3)/AFP ≤400 ng/mL (TTV/AFP) model [129]. The gene discussed is AFP; the disease is neoplasm.